270 related articles for article (PubMed ID: 33317799)
1. Benign or not benign? Deep phenotyping of liver Glycogen Storage Disease IX.
Fernandes SA; Cooper GE; Gibson RA; Kishnani PS
Mol Genet Metab; 2020 Nov; 131(3):299-305. PubMed ID: 33317799
[TBL] [Abstract][Full Text] [Related]
2. Characterization of liver GSD IX γ2 pathophysiology in a novel Phkg2
Gibson RA; Lim JA; Choi SJ; Flores L; Clinton L; Bali D; Young S; Asokan A; Sun B; Kishnani PS
Mol Genet Metab; 2021 Jul; 133(3):269-276. PubMed ID: 34083142
[TBL] [Abstract][Full Text] [Related]
3. Diagnosis and management of glycogen storage diseases type VI and IX: a clinical practice resource of the American College of Medical Genetics and Genomics (ACMG).
Kishnani PS; Goldstein J; Austin SL; Arn P; Bachrach B; Bali DS; Chung WK; El-Gharbawy A; Brown LM; Kahler S; Pendyal S; Ross KM; Tsilianidis L; Weinstein DA; Watson MS;
Genet Med; 2019 Apr; 21(4):772-789. PubMed ID: 30659246
[TBL] [Abstract][Full Text] [Related]
4. Glycogen storage disease type IX: High variability in clinical phenotype.
Beauchamp NJ; Dalton A; Ramaswami U; Niinikoski H; Mention K; Kenny P; Kolho KL; Raiman J; Walter J; Treacy E; Tanner S; Sharrard M
Mol Genet Metab; 2007; 92(1-2):88-99. PubMed ID: 17689125
[TBL] [Abstract][Full Text] [Related]
5. Molecular diagnosis of glycogen storage disease type IX using a glycogen storage disease gene panel.
Kim TH; Kim KY; Kim MJ; Seong MW; Park SS; Moon JS; Ko JS
Eur J Med Genet; 2020 Jun; 63(6):103921. PubMed ID: 32244026
[TBL] [Abstract][Full Text] [Related]
6. A Mouse Model of Glycogen Storage Disease Type IX-Beta: A Role for
Arends CJ; Wilson LH; Estrella A; Kwon OS; Weinstein DA; Lee YM
Int J Mol Sci; 2022 Sep; 23(17):. PubMed ID: 36077341
[TBL] [Abstract][Full Text] [Related]
7. Identification of a novel mutation in the PHKA2 gene in a child with liver cirrhosis.
Beyzaei Z; Ezgu F; Imanieh MH; Geramizadeh B
J Pediatr Endocrinol Metab; 2022 Mar; 35(3):417-420. PubMed ID: 34727590
[TBL] [Abstract][Full Text] [Related]
8. The Phenotypic and Genetic Spectrum of Glycogen Storage Disease Type VI.
Grünert SC; Hannibal L; Spiekerkoetter U
Genes (Basel); 2021 Aug; 12(8):. PubMed ID: 34440378
[TBL] [Abstract][Full Text] [Related]
9. Novel PHKG2 mutation causing GSD IX with prominent liver disease: report of three cases and review of literature.
Albash B; Imtiaz F; Al-Zaidan H; Al-Manea H; Banemai M; Allam R; Al-Suheel A; Al-Owain M
Eur J Pediatr; 2014 May; 173(5):647-53. PubMed ID: 24326380
[TBL] [Abstract][Full Text] [Related]
10. Mutations in the testis/liver isoform of the phosphorylase kinase gamma subunit (PHKG2) cause autosomal liver glycogenosis in the gsd rat and in humans.
Maichele AJ; Burwinkel B; Maire I; Søvik O; Kilimann MW
Nat Genet; 1996 Nov; 14(3):337-40. PubMed ID: 8896567
[TBL] [Abstract][Full Text] [Related]
11. A novel PHKA2 mutation in a Chinese child with glycogen storage disease type IXa: a case report and literature review.
Fu J; Wang T; Xiao X
BMC Med Genet; 2019 Mar; 20(1):56. PubMed ID: 30925902
[TBL] [Abstract][Full Text] [Related]
12. Expected or unexpected clinical findings in liver glycogen storage disease type IX: distinct clinical and molecular variability.
İnci A; Kılıç Yıldırım G; Cengiz Ergin FB; Sarı S; Eğritaş Gürkan Ö; Okur İ; Biberoğlu G; Bükülmez A; Ezgü FS; Dalgıç B; Tümer L
J Pediatr Endocrinol Metab; 2022 Apr; 35(4):451-462. PubMed ID: 35038814
[TBL] [Abstract][Full Text] [Related]
13. Liver glycogen storage diseases due to phosphorylase system deficiencies: diagnosis thanks to non invasive blood enzymatic and molecular studies.
Davit-Spraul A; Piraud M; Dobbelaere D; Valayannopoulos V; Labrune P; Habes D; Bernard O; Jacquemin E; Baussan C
Mol Genet Metab; 2011; 104(1-2):137-43. PubMed ID: 21646031
[TBL] [Abstract][Full Text] [Related]
14. The natural history of glycogen storage disease types VI and IX: Long-term outcome from the largest metabolic center in Canada.
Roscher A; Patel J; Hewson S; Nagy L; Feigenbaum A; Kronick J; Raiman J; Schulze A; Siriwardena K; Mercimek-Mahmutoglu S
Mol Genet Metab; 2014 Nov; 113(3):171-6. PubMed ID: 25266922
[TBL] [Abstract][Full Text] [Related]
15. Variability of disease spectrum in children with liver phosphorylase kinase deficiency caused by mutations in the PHKG2 gene.
Bali DS; Goldstein JL; Fredrickson K; Rehder C; Boney A; Austin S; Weinstein DA; Lutz R; Boneh A; Kishnani PS
Mol Genet Metab; 2014 Mar; 111(3):309-313. PubMed ID: 24389071
[TBL] [Abstract][Full Text] [Related]
16. Novel mutations in PHKA2 gene in glycogen storage disease type IX patients from Hong Kong, China.
Lau CK; Hui J; Fong FN; To KF; Fok TF; Tang NL; Tsui SK
Mol Genet Metab; 2011 Feb; 102(2):222-5. PubMed ID: 21131218
[TBL] [Abstract][Full Text] [Related]
17. Report of an Iranian child with chronic abdominal pain and constipation diagnosed as glycogen storage disease type IX: a case report.
Zamanfar D; Hashemi-Soteh SM; Ghazaiean M; Keyhanian E
J Med Case Rep; 2024 Jan; 18(1):14. PubMed ID: 38212860
[TBL] [Abstract][Full Text] [Related]
18. Clinical and genetic characteristics of 17 Chinese patients with glycogen storage disease type IXa.
Zhang J; Yuan Y; Ma M; Liu Y; Zhang W; Yao F; Qiu Z
Gene; 2017 Sep; 627():149-156. PubMed ID: 28627441
[TBL] [Abstract][Full Text] [Related]
19. PHKG2 mutation spectrum in glycogen storage disease type IXc: a case report and review of the literature.
Li C; Huang L; Tian L; Chen J; Li S; Yang Z
J Pediatr Endocrinol Metab; 2018 Mar; 31(3):331-338. PubMed ID: 29360628
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
